LFSC

F/m Emerald Life Sciences Innovation ETF

$33.77

+0.00%

Market closed. Last update: 11:59 AM ET

📎 Investment Objective

The F/m Emerald Life Sciences Innovation ETF (LFSC) seeks to provide investment results that, before fees and expenses, correspond generally to the performance of the Emerald Life Sciences Innovation Index.

Overview

ETF tracking F/m Emerald Life Sciences Innovation ETF

Category Innovation

Issuer Other

Inception Date 2024-10-31

Market Cap $79.6M

Average Volume N/A

Dividend Yield N/A

52-Week Range $19.19 - $34.84

VWAP $33.74

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

🎯 Investment Strategy

The ETF uses a passive management (or index-tracking) strategy designed to track the performance of the underlying index. The index is composed of companies that are involved in the research, development, production, and distribution of innovative life sciences products and services.

✨ Key Features

Focuses on companies in the life sciences and biotechnology sectors
Passively tracks the Emerald Life Sciences Innovation Index
Low expense ratio of 0.00%
Recently launched with no performance history yet

⚠️ Primary Risks

Sector concentration risk as the fund is focused on the life sciences industry
Potential for high volatility as the biotechnology and life sciences sectors can be risky
Lack of performance history makes it difficult to evaluate long-term returns
Low assets under management may impact liquidity and trading efficiency

👤 Best For

The F/m Emerald Life Sciences Innovation ETF may be suitable for investors seeking exposure to innovative companies in the life sciences and biotechnology sectors as part of a diversified portfolio. However, due to the fund's lack of performance history and high sector concentration, it may be more appropriate for investors with a higher risk tolerance and a longer investment time horizon.